Skip to content
7 min read National Report

Outbreak Outlook - National - Nov 16

A look at the upcoming flu season, including H3N2

Outbreak Outlook - National - Nov 16

Respiratory Diseases

Influenza-like illness

Flu is still low, but activity is rising rapidly. There are a few different signals that suggest this be a rough flu season, despite its slow start in the United States. Other countries have been reporting a particularly early and rough start to their flu seasons, including Japan and the United Kingdom. Their activity is spurred by a new subclade of H3N2 that was first recognized over the summer. H3N2 now accounts for the majority (72%) of subtyped flu infections in the U.S, and subclade K represents about half of those.

H3N2 has in recent years been linked to generally more severe flu seasons. This year’s flu vaccine strain was selected before the new subclade emerged, which means there might be some mismatch between the circulating virus and the vaccine. Nevertheless, the best protection against a bad flu season is to be vaccinated, and encouragingly, preliminary data from the UK suggests that this year’s vaccine is proving to be about as effective at decreasing the risk of hospitalizations for children and adults as in many recent years. However, the UK uses more live attenuated and cell-based flu vaccines than we do in the U.S., so I would not be surprised if they see better vaccine performance.

What is happening right now in the U.S.? The estimated reproductive number is 1.23 nationally, which means that activity is growingly quickly. The CDC’s Center for Forecasting and Outbreak Analytics estimates that flu activity is increasing in all other states for which data are available (39 states total).

While activity is growing rapidly, for the moment, in most states activity remains minimal or low. Outpatient influenza-like illness (ILI) is low but rising, with 2.1% of outpatient visits in the past week due to ILI. As a reminder, outpatient ILI is the percentage of visits to the doctor that are for fever and cough or sore throat. After several weeks of gradual increases, this past week, ILI increased more sharply.

Outpatient ILI visits are rising for all age groups, but have particularly jumped up for those aged 0-4 (to 7.0%), and 5-24 (3.5%). All other age groups are reporting outpatient ILI rates of <1.75%.

Similarly, ED visits for flu are low but have doubled in the past two weeks, to 0.4%. Hospitalizations are also slowly increasing, though they remain quite low at the moment.

What to do: If you haven’t gotten your flu shot yet, get to it right away. And if you are someone who takes extra precautions based on what’s going around, I recommend ramping up soon. While activity is currently low, that’s changing quickly.


COVID-19

Covid-19 activity remains very low. ED visits continue to decline in all four regions, and are at a very low 0.3% nationally. Similarly, hospitalizations continue to fall and are currently lower than they have been in the last year (0.9 hospitalizations per 100,000).

A handful of states in most regions (except the Northeast) have reported some small increases — including New Mexico, Tennessee, and Kansas — but nothing that I am worried about yet.


RSV & Other Bugs

RSV activity is low and rising slowly, particularly in the South. ED visits are picking up for the youngest kids (under 5). Hospitalizations are very low at 0.3 hospitalizations per 100,000 population.

Some new research demonstrates that vaccination against RSV for older adults is highly effective at reducing hospital admissions for RSV. The study looked at adults between 75-79 years old who were admitted to the hospital with acute respiratory infection for more than one day and who received diagnostic essays within 48 hours of admission, and compared those who were positive for RSV with those who were negative, and their vaccination statuses. The RSV vaccine was shown to be 82.3% effective against hospitalization for any RSV-associated acute respiratory infection. These numbers drop slightly for those who had exacerbation of underlying health conditions, such as chronic lung disease or chronic heart disease. Nevertheless, they remain >75%. There is need for additional research to look at how protective the vaccine is in other patient populations — but this research confirms that RSV vaccination for elderly adults is highly effective at decreasing severe outcomes.

Other bugs:


Norovirus

Norovirus test positivity data is back online for the first time in a few months, just in time to tell us that norovirus activity is on the rise.

Nationally, norovirus is up to 11.2% test positivity, from a low of 6.5% over the summer. As a reminder, norovirus causes vomiting, diarrhea, and stomach pain and it spreads extremely efficiently, including in the couple days after symptoms have resolved.

The South has seen explosive growth in the past few weeks, and is now at 17.3% test positivity, and is still rising. It is currently higher than at any point reached in over the past year (and last year was a rough season).

In the West, activity is on a jagged upward path, and after a slight decline over the past month, has increased again to 10.0% test positivity. In the Midwest, after a very rough season, activity levels never quite reached as low as they usually do over the summer months, and have been slowly and steadily rising since late August. As of now, they are at 9.8%. In the Northeast, activity is still fairly low (at 7.6%) but on an overall upward trajectory.


Food recalls

The following foods are being recalled because they are contaminated. Please check your cupboards and throw out any of these items:

The following foods are being recalled because they are contaminated. Please check your cupboards and throw out any of these items:

New:

Previously Reported:


In other news